Literature DB >> 34597386

Differences in Symptomatic Presentation and Cognitive Performance Among Participants With LATE-NC Compared to FTLD-TDP.

Merilee A Teylan1, Charles Mock1, Kathryn Gauthreaux1, Jessica E Culhane1, Gregory Jicha1, Yen-Chi Chen1, Kwun C G Chan1, Walter A Kukull1, Peter T Nelson1, Yuriko Katsumata1.   

Abstract

Transactive response DNA-binding protein 43 kDa (TDP-43) is aberrantly aggregated and phosphorylated in frontotemporal lobar degeneration of the TDP-43 type (FTLD-TDP), and in limbic-predominant age-related TDP-43 encephalopathy neuropathologic change (LATE-NC). We examined data from the National Alzheimer's Coordinating Center to compare clinical features of autopsy-confirmed LATE-NC and FTLD-TDP. A total of 265 LATE-NC and 92 FTLD-TDP participants were included. Cognitive and behavioral symptoms were compared, stratified by level of impairment based on global clinical dementia rating (CDR) score. LATE-NC participants were older at death, more likely to carry APOE ε4, more likely to have Alzheimer disease neuropathology, and had lower (i.e. less severe) final CDR global scores than those with FTLD-TDP. Participants with FTLD-TDP were more likely to present with primary progressive aphasia, or behavior problems such as apathy, disinhibition, and personality changes. Among participants with final CDR score of 2-3, those with LATE-NC were more likely to have visuospatial impairment, delusions, and/or visual hallucinations. These differences were robust after sensitivity analyses excluding older (≥80 years at death), LATE-NC stage 3, or severe Alzheimer cases. Overall, FTLD-TDP was more globally severe, and affected younger participants, whereas psychoses were more common in LATE-NC.
© 2021 American Association of Neuropathologists, Inc. All rights reserved.

Entities:  

Keywords:  FTD; Frontotemporal; Neuropsychiatric; Plaques; Tangles

Mesh:

Substances:

Year:  2021        PMID: 34597386      PMCID: PMC8921612          DOI: 10.1093/jnen/nlab098

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  31 in total

1.  Prediction of preclinical Alzheimer's disease: longitudinal rates of change in cognition.

Authors:  Kathryn P Riley; Gregory A Jicha; Daron Davis; Erin L Abner; Gregory E Cooper; Nancy Stiles; Charles D Smith; Richard J Kryscio; Peter T Nelson; Linda J Van Eldik; Frederick A Schmitt
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

Review 2.  Tau and TDP-43 proteinopathies: kindred pathologic cascades and genetic pleiotropy.

Authors:  Yevgen Chornenkyy; David W Fardo; Peter T Nelson
Journal:  Lab Invest       Date:  2019-02-11       Impact factor: 5.662

Review 3.  Frontotemporal lobar degeneration: Pathogenesis, pathology and pathways to phenotype.

Authors:  David M A Mann; Julie S Snowden
Journal:  Brain Pathol       Date:  2017-03-02       Impact factor: 6.508

4.  The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers.

Authors:  John C Morris; Sandra Weintraub; Helena C Chui; Jeffrey Cummings; Charles Decarli; Steven Ferris; Norman L Foster; Douglas Galasko; Neill Graff-Radford; Elaine R Peskind; Duane Beekly; Erin M Ramos; Walter A Kukull
Journal:  Alzheimer Dis Assoc Disord       Date:  2006 Oct-Dec       Impact factor: 2.703

5.  TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease.

Authors:  Catalina Amador-Ortiz; Wen-Lang Lin; Zeshan Ahmed; David Personett; Peter Davies; Ranjan Duara; Neill R Graff-Radford; Michael L Hutton; Dennis W Dickson
Journal:  Ann Neurol       Date:  2007-05       Impact factor: 10.422

6.  Protein contributions to brain atrophy acceleration in Alzheimer's disease and primary age-related tauopathy.

Authors:  Keith A Josephs; Peter R Martin; Stephen D Weigand; Nirubol Tosakulwong; Marina Buciuc; Melissa E Murray; Leonard Petrucelli; Matthew L Senjem; Anthony J Spychalla; David S Knopman; Bradley F Boeve; Ronald C Petersen; Joseph E Parisi; Dennis W Dickson; Clifford R Jack; Jennifer L Whitwell
Journal:  Brain       Date:  2020-12-05       Impact factor: 13.501

7.  Hippocampal Sclerosis in Frontotemporal Dementia: When Vascular Pathology Meets Neurodegeneration.

Authors:  Anne Sieben; Tim Van Langenhove; Yannick Vermeiren; Helena Gossye; Marleen Praet; Dimitri Vanhauwaert; Céline Cousaert; Sebastiaan Engelborghs; Robrecht Raedt; Paul Boon; Patrick Santens; Peter Paul De Deyn; Ken R Bracke; Katia De Meulemeester; Christine Van Broeckhoven; Jean-Jacques Martin; Maria Bjerke
Journal:  J Neuropathol Exp Neurol       Date:  2021-03-22       Impact factor: 3.685

8.  Rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer's disease: a longitudinal retrospective study.

Authors:  Keith A Josephs; Dennis W Dickson; Nirubol Tosakulwong; Stephen D Weigand; Melissa E Murray; Leonard Petrucelli; Amanda M Liesinger; Matthew L Senjem; Anthony J Spychalla; David S Knopman; Joseph E Parisi; Ronald C Petersen; Clifford R Jack; Jennifer L Whitwell
Journal:  Lancet Neurol       Date:  2017-09-11       Impact factor: 44.182

9.  Neuropsychiatric symptoms in limbic-predominant age-related TDP-43 encephalopathy and Alzheimer's disease.

Authors:  Kathy Y Liu; Suzanne Reeves; Kirsty E McAleese; Johannes Attems; Paul Francis; Alan Thomas; Robert Howard
Journal:  Brain       Date:  2020-11-14       Impact factor: 13.501

10.  Limbic-predominant age-related TDP-43 encephalopathy differs from frontotemporal lobar degeneration.

Authors:  John L Robinson; Sílvia Porta; Filip G Garrett; Panpan Zhang; Sharon X Xie; EunRan Suh; Vivianna M Van Deerlin; Erin L Abner; Gregory A Jicha; Justin M Barber; Virginia M-Y Lee; Edward B Lee; John Q Trojanowski; Peter T Nelson
Journal:  Brain       Date:  2020-09-01       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.